‌

US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof

Patent 10597464 was granted and assigned to Genmab A/S on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 24, 2020

Patent Application Number

15414122

Date Filed

January 24, 2017

Patent Citations

US Patent 10344050 Production of heterodimeric proteins

0

US Patent 10239952 Anti-WT1/HLA bi-specific antibody

Patent Citations Received

US Patent 12121587 Dimeric antibodies

0

US Patent 11492371 Production of heterodimeric proteins

0

US Patent 11512137 Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

US Patent 11970544 Antibodies

0

US Patent 12116410 Methods of manufacturing dimeric antibodies

0

US Patent 11471490 T cells surface-loaded with immunostimulatory fusion molecules and uses thereof

0

US Patent 11535679 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma

0

US Patent 11548952 Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma

0

...

Patent Primary Examiner

Jessica H Roark

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.